IBSA Derma and Alma together for the future of aesthetic medicine13 June 2019
Spot and invasive interventions are the past: aesthetic medicine is increasingly understood as an ongoing path of prevention and treatment. For this reason IBSA Derma has started a partnership with Alma, a leading company in the design and production of medical devices using laser technology, which shares the values of innovation, technology and the preservation of authentic beauty.
Hyaluronic acid produced by IBSA and Alma medical devices are cutting-edge technologies that ensure a holistic approach to a person’s aesthetic well-being. The advantages of their joint use will soon be demonstrated by a study conducted by the University of Modena. The partnership in the field of aesthetic medicine was announced at the 2019 World Dermatology Conference in Milan from 10 to 15 June 2019. It is one of IBSA's many initiatives for improving people’s well-being, both therapeutically and socially.